Acuren Corporation (TIC) 2024年年度报告「NYSE」.pdf

1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K(Mark One)xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2024ORoTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES

2、EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIODFROM TO Commission File Number 001-42524Acuren Corporation(Exact name of Registrant as specified in its Charter)Delaware66-1076867(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)14434 Medical Complex Drive,S

3、uite 100 Tomball,Texas77377(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(800)218-7450Securities registered pursuant to Section 12(b)of the Act:Title of each classTradingSymbol(s)Name of each exchange on which registeredCommon Stock,par value$0.00

4、01 per shareTICNYSE AmericanSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the Registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes o No xIndicate by check mark if the Registrant is not required to file reports pursuant

5、to Section 13 or 15(d)of the Act.Yes o No xIndicate by check mark whether the Registrant:(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for suchshorter period that the Registrant was required to file such r

6、eports),and(2)has been subject to such filing requirements for the past 90 days.Yes x No oIndicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the precedin